SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-057282
Filing Date
2015-09-29
Accepted
2015-09-29 21:36:55
Documents
1
Period of Report
2015-09-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v421296_4.html 4  
1 OWNERSHIP DOCUMENT v421296_4.xml 4 4555
  Complete submission text file 0001144204-15-057282.txt   5991
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS INC 400 OYSTER POINT BLVD S SAN FRANCISCO CA 94080
Business Address
BHONSLE SUNIL (Reporting) CIK: 0001180755 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27436 | Film No.: 151132083